Individuals with Hematological Malignancies Before Undergoing Chemotherapy Present Oxidative Stress Parameters and Acute Phase Proteins Correlated with Nutritional Status

REFERENCES

• Ruddon RW: Cancer Biology. Oxford, UK: Oxford University Press, 2007.
   Google Scholar
• National Cancer Institute: Cancer Topics—Leukemia. United States of America: NCI, 2013. Retrieved from http://www.cancer.gov/cancertopics/types/leukemia
   Google Scholar
• Ginderachter JA, Movahedi K, Ghassabeh GH, Meerschaut S, Beschin A, et al.: Classical and alternative activation of mononuclear phagocytes: Picking the best of both worlds for tumor promotion. Immunobiology 211, 487–501, 2006.
   PubMed Web of Science ®Google Scholar
• Siveen KS and Kuttan G: Role of macrophages in tumour progression. Immunol Lett 123, 97–102, 2009.
   PubMed Web of Science ®Google Scholar
• Irwin ME, Rivera-Del Valle N, and Chandra J: Redox control of leukemia: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 18, 1349–1383, 2013.
   PubMed Web of Science ®Google Scholar
• Karihtala P and Soini Y: Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies. Acta Pathol Microbiol Immunol 115, 81–103, 2007.
   PubMed Web of Science ®Google Scholar
• Negre-Salvayre A, Auge N, Ayala V, Basaga H, Boada J, et al.:. Pathological aspects of lipid peroxidation. Free Radic Res 44, 1125–1171, 2010.
   PubMed Web of Science ®Google Scholar
• Brasil Ministério da Saúde, Instituto Nacional de Câncer, Consenso Nacional de Nutrição Oncológica. Rio de Janeiro, Brazil: Inca, 2009.
   Google Scholar
• Mcmillan DC: Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 12, 223–226, 2009.
   PubMed Web of Science ®Google Scholar
• Frisancho AR: New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr 34, 2540–2545, 1981.
   PubMed Web of Science ®Google Scholar
• World Health Organization: Physical Status: The Use and Interpretation of Antropometry (Technical Report, nº. 854). Geneva, Switzerland: World Health Organization, 1995.
   Google Scholar
• Rosen, H and Gordon S: Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo. Journal of Experimental Medicine 166, 1685–1701, 1987.
   PubMed Web of Science ®Google Scholar
• Pipe RK, Coles JA, and Farley SR: Assays for measuring immune response in the mussel Mytilus edulis. Technology Fish Immunology 4, 93–100, 1995.
   Google Scholar
• Choi HS, Kim JW, Cha YN, and Kim C: A quantitative nitroblue tetrazolium assay for determining intracellular superoxide anion production in phagocytic cells. J Immunoassay Immunochem 27, 31–44, 2006.
   PubMed Web of Science ®Google Scholar
• Aebi H: Catalase in vitro. Methods Enzymol 105, 121–126, 1984.
   PubMed Web of Science ®Google Scholar
• Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities utilizing the principle of protein dye binding. An Biochem 142, 79–83, 1976.
   Google Scholar
• Nourooz-Zadeh J, Tajaddini-Sarmadi J, and Wolff SP: Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal Biochem 220, 403–409, 1994.
   PubMed Web of Science ®Google Scholar
• Ledue TB, Weiner DL, Sipe JD, Poulin SE, et al.: Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann Clin Biochem 35, 745–753, 1998.
   PubMed Web of Science ®Google Scholar
• Lasky FD, Li ZM, and Shaver DD: Evaluation of a bromocresol purple method for the determination of albumin adapted to the DuPont aca discrete clinical analyzer. Clin Biochem 18, 290–296, 1985.
   PubMed Web of Science ®Google Scholar
• Blackburn GL, Bistrian BR, Maini BS, Schlamm HT, and Smith MF: Nutritional and metabolic assessment of the hospitalized patient. J Parent Enter Nutr 1, 11–22, 1977.
   PubMedGoogle Scholar
• Malihi Z, Kandiah M, Chan YM, Hosseinzadeh M, Azadi MS, et al.: Nutritional status and quality of life in patients with acute leukaemia prior to and after induction chemotherapy in three hospitals in Tehran, Iran: a prospective study. J Hum Nutr Diet 26(Suppl 1), 123–131, 2013.
   PubMed Web of Science ®Google Scholar
• Brunner AM, Sadrzadeh H, Feng Y, Drapkin BJ, Ballen KK, et al.: Association between baseline body mass index and overall survival among patients over age 60 with acute myeloid leukemia. Am J Hematol 88, 642–646, 2013.
   PubMed Web of Science ®Google Scholar
• Medeiros BC, Othus M, Estey EH, Fang M, and Appelbaum FR: Impact of body-mass index on the outcome of adult patients with acute myeloid leukemia. Haematologica 97, 1401–1404, 2012.
   PubMed Web of Science ®Google Scholar
• Carson KR, Bartlett NL, Mcdonald JR, Luo S, Zeringue A, et al.: Increased body mass index is associated with improved survival in United States veterans with diffuse large B-cell lymphoma. J Clin Oncol 30, 3217–3222, 2012.
   PubMed Web of Science ®Google Scholar
• Gupta D and Lis CG: Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature. Nutrition Journal 9, 2–16, 2010.
   PubMed Web of Science ®Google Scholar
• MacInnis RJ, English DR, Hopper JL, and Giles GG: Body size and composition and the risk of lymphohematopoietic malignancies. J Natl Cancer Inst 97, 1154–1157, 2005.
   PubMed Web of Science ®Google Scholar
• Söderberg K, Kaprio J, Verkasalo PK, Pukkala E, Koskenvuo M, et al.: Overweight, obesity and risk of haematological malignancies: a cohort study of Swedish and Finnish twins. Eur J Cancer 45, 1232–1238, 2009.
   PubMed Web of Science ®Google Scholar
• Majello B, Arcone R, Toniatti C, and Ciliberto G: Constitutive and IL-6-induced nuclear factors that interact with the human C-reactive protein promoter. The EMBO Journal 9, 457–465, 1990.
   PubMed Web of Science ®Google Scholar
• Cao Y, Shi Y, Chen J, Tan Y, Cai Y, et al.: Serum C-reactive protein as an important prognostic variable in patients with diffuse large B cell lymphoma. Tumor Biology 33, 1039–1044, 2012.
   PubMed Web of Science ®Google Scholar
• Li Y, Li Z, Xia Y, Huang J, Huang H, et al.:. Serum C-reactive protein (CRP) as a simple and independent prognostic factor in extranodal natural killer/T-cell lymphoma. nasal type. Plos One 8, e64158, 2013.
   Web of Science ®Google Scholar
• Crozier JE, Leitch EF, McKee RF, Anderson JH, Horgan PG, et al.: Relationship between emergency presentation, systemic inflammatory response, and cancer-specific survival in patients undergoing potentially curative surgery for colon cancer. The American Journal of Surgery 197, 544–549, 2009.
   PubMed Web of Science ®Google Scholar
• Levine AS, Siegel SE, Schreiber AD, Hauser J, Preisler H, et al.: Protected environments and prophylactic antibiotics—a prospective controlled study of their utility in the therapy of acute leukemia. N Engl J Med 288, 477–483, 1973.
   PubMed Web of Science ®Google Scholar
• Hofmann WK, Stauch M, and Hoffken K: Impaired granulocytic function in patients with acute leukaemia: only partial normalisation after successful remission-inducing treatment. J Cancer Res Clin Oncol 124, 113–116, 1998.
   PubMed Web of Science ®Google Scholar
• Hubel K, Hegener K, Schnell R, Mansmann G, Oberhauser F, et al.: Suppressed neutrophil function as a risk factor for severe infection after cytotoxic chemotherapy in patients with acute nonlymphocytic leukemia. Ann Hematol 78, 73–77, 1999.
   PubMed Web of Science ®Google Scholar
• Er T, Tsai S, Wu S, Chiang W, Lin H, et al.: Antioxidant status and superoxide anion radical generation in acute myeloid leukemia. Clin Biochem 40, 1015–1019, 2007.
   PubMed Web of Science ®Google Scholar
• Tanaka M, Kuribayashi K, Kogawa K, Nakamura K, and Watanabe N: Intracellular superoxide dismutase activity defines invasiveness of the murine T-lymphoma cell line L5187Y-ML25 in vitro and in vivo. Leuk Res 37, 89–92, 2013.
   PubMed Web of Science ®Google Scholar
• Zelen I, Djurdjevic P, Popovic S, Stojanovic M, Jakovljevic V, et al.:. Antioxidant enzymes activities and plasma levels of oxidative stress markers in B chronic lymphocytic leukemia patients. J Buon 15, 330–336, 2010.
   PubMed Web of Science ®Google Scholar
• Collado R,Oliver I, Tormos C, Egea M, Miguel A, et al.:. Early ROS-mediated DNA damage and oxidative stress biomarkers in Monoclonal B Lymphocytosis. Cancer Lett 317, 144–149, 2012.
   PubMed Web of Science ®Google Scholar
• Zaric M, Mitrovic M, Nikolic I, Popovic S, Djurdjevic P, et al.: Activity of superoxide dismutase, catalase, and glutathione peroxidase in plasma and lysates of chronic lymphocytic leukemia patients. Med Cas 45, 9–16, 2011.
   Google Scholar
• Devi GS, Prasad MH, Saraswathi I, Raghu D, Rao DN, et al.: Free radicals antioxidant enzymes and lipid peroxidation in different types of leukemias. Clin Chim Acta 293, 53–62, 2000.
   PubMed Web of Science ®Google Scholar
• Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, et al.: Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114, 1752–1761, 2004.
   PubMed Web of Science ®Google Scholar
• Ahmad R, Tripathi AK, Tripathi P, Singh R, Singh S, et al.: Oxidative stress and antioxidant status in patients with chronic myeloid leukemia. Indian J Clin Biochem 23, 328–333, 2008.
   PubMedGoogle Scholar
• Ahmad R, Tripathi AK, Tripathi P, Singh R, Singh S, et al.: Studies on lipid peroxidation and nonenzymatic antioxidant status as indices of oxidative stress in patients with chronic myeloid leukaemia. Singapore Med J 51, 110–115, 2010.
   PubMed Web of Science ®Google Scholar